| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1999;34:403-407.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
2A-Adrenergic Receptor Subtype
From the Hypertension and Atherosclerosis Section, Boston University School of Medicine (K.P.M., C.J., I.G., D.E.H., M.R.B., H.G.), Boston, Mass; and Howard Hughes Medical Institute, Stanford University (J.D.A.), Stanford, Calif.
Correspondence to Haralambos Gavras, MD, Chief, Hypertension and Atherosclerosis Section, Boston University School of Medicine, 715 Albany St, Boston, MA 02118. E-mail hgavras{at}bu.edu
AbstractPresynaptic
2-adrenergic receptors (
2-AR) are
distributed throughout the central nervous system and are highly
concentrated in the brain stem, where they contribute to neural
baroreflex control of blood pressure (BP). To explore the role of the
2A-AR subtype in this function, we compared BP and
plasma norepinephrine and epinephrine levels in
genetically engineered mice with deleted
2A-AR gene to
their wild-type controls. At baseline, the
2A-AR gene
knockouts (n=11) versus controls (n=10) had higher systolic BP
(123±2.5 versus 115±2.5 mm Hg, P<0.05), heart
rate (730±15 versus 600±18 b/min, P<0.001), and
norepinephrine (1.005±0.078 versus 0.587±0.095 ng/mL,
P<0.01), respectively. When submitted to subtotal
nephrectomy and given 1% saline as drinking water, both
2A-AR gene knockouts (n=14) and controls (n=14) became
hypertensive, but the former required 15.6±2.5 days versus 29.3±1.4
days for the controls (P<0.001). End-point
systolic BP was similar for both at 155±2.1 versus
152±5.2 mm Hg, but norepinephrine and
epinephrine levels were twice as high in the knockouts at
1.386±0.283 and 0.577±0.143 versus 0.712±0.110 and 0.255±0.032
ng/mL, respectively, P<0.05 for both. We conclude that
the
2A-AR subtype exerts a
sympathoinhibitory effect, and its loss leads to a
hypertensive, hyperadrenergic state.
Key Words: adrenergic receptors mice, knockout hypertension, sodium-dependent hyperadrenergic state
This article has been cited by other articles:
![]() |
D. V. Menon, Z. Wang, P. J. Fadel, D. Arbique, D. Leonard, J.-L. Li, R. G. Victor, and W. Vongpatanasin Central Sympatholysis as a Novel Countermeasure for Cocaine-Induced Sympathetic Activation and Vasoconstriction in Humans J. Am. Coll. Cardiol., August 14, 2007; 50(7): 626 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck Lys418Asn Polymorphism of the {alpha}2-Adrenoceptor Gene Relates to Serum Uric Acid Levels But Not to Insulin Sensitivity Hypertension, July 1, 2005; 46(1): 144 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Finley Jr., M. O'Leary, D. Wester, S. MacKenzie, N. Shepard, S. Farrow, and W. Lockette A genetic polymorphism of the {alpha}2-adrenergic receptor increases autonomic responses to stress J Appl Physiol, June 1, 2004; 96(6): 2231 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tank, J. Jordan, A. Diedrich, M. Obst, R. Plehm, F. C. Luft, and V. Gross Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Mice Through Parasympathetic Activation Hypertension, May 1, 2004; 43(5): 1042 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Peng, B. D. Chambless, S. Oparil, and J. M. Wyss {alpha}2A-Adrenergic Receptors Mediate Sympathoinhibitory Responses to Atrial Natriuretic Peptide in the Mouse Anterior Hypothalamic Nucleus Hypertension, March 1, 2003; 41(3): 571 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brede, F. Wiesmann, R. Jahns, K. Hadamek, C. Arnolt, S. Neubauer, M. J. Lohse, and L. Hein Feedback Inhibition of Catecholamine Release by Two Different {alpha}2-Adrenoceptor Subtypes Prevents Progression of Heart Failure Circulation, November 5, 2002; 106(19): 2491 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Plut, C. Ribiere, Y. Giudicelli, and J.-P. Dausse Gender Differences in Hypothalamic Tyrosine Hydroxylase and alpha 2-Adrenoceptor Subtype Gene Expression in Cafeteria Diet-Induced Hypertension and Consequences of Neonatal Androgenization J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 525 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Philipp, M. Brede, and L. Hein Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R287 - R295. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khalid, Y. Giudicelli, and J.-P. Dausse An Up-Regulation of Renal alpha 2A-Adrenoceptors Is Associated with Resistance to Salt-Induced Hypertension in Sabra Rats J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 928 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. X. Li, M. Bek, L. D. Asico, Z. Yang, D. K. Grandy, D. S. Goldstein, M. Rubinstein, G. M. Eisner, and P. A. Jose Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice Hypertension, September 1, 2001; 38(3): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice Cardiovasc Res, June 1, 2001; 50(3): 443 - 453. [Full Text] [PDF] |
||||
![]() |
J. W. Kable, L. C. Murrin, and D. B. Bylund In Vivo Gene Modification Elucidates Subtype-Specific Functions of alpha 2-Adrenergic Receptors J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 1 - 7. [Abstract] [Full Text] |
||||
![]() |
K. P. Makaritsis, C. Johns, I. Gavras, and H. Gavras Role of {alpha}2-Adrenergic Receptor Subtypes in the Acute Hypertensive Response to Hypertonic Saline Infusion in Anephric Mice Hypertension, February 1, 2000; 35(2): 609 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Small, S. L. Forbes, K. M. Brown, and S. B. Liggett An Asn to Lys Polymorphism in the Third Intracellular Loop of the Human alpha 2A-Adrenergic Receptor Imparts Enhanced Agonist-promoted Gi Coupling J. Biol. Chem., December 1, 2000; 275(49): 38518 - 38523. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Zuscik, D. Chalothorn, D. Hellard, C. Deighan, A. McGee, C. J. Daly, D. J. J. Waugh, S. A. Ross, R. J. Gaivin, A. J. Morehead, et al. Hypotension, Autonomic Failure, and Cardiac Hypertrophy in Transgenic Mice Overexpressing the alpha 1B-Adrenergic Receptor J. Biol. Chem., April 20, 2001; 276(17): 13738 - 13743. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |